GENerX Life

2025 is set to be a transformative year for the pharmaceutical industry. In our latest article, we break down the looming “patent cliff” as blockbuster drugs lose exclusivity - opening the door for generics and biosimilars, and reshaping pricing, regulation, and competitive strategies. We explore how this shift will drive innovation, impact R&D spending, and change the talent landscape across the industry. Check it out and join the discussion on how these changes could redefine the industry! #PatentCliff #Pharma #Biotech #Generics #Biosimilars

For many founders and business leaders, hiring HR can feel like a pivotal moment - one where agility is replaced by bureaucracy, and entrepreneurial spirit gives way to process and policies. But is that really the case? Or is it simply a misunderstanding of the true role HR plays in business success? At GENerX Life, we believe HR isn’t a roadblock; it’s a strategic enabler of growth, culture, and long-term success. To explore this further, we sat down with our newest Board Advisor, Barbara Greutter, a seasoned CHRO with over 20 years of experience leading HR strategies in Pharma, Biotech, Tech, and Consulting. Barbara has worked with leadership teams on scaling businesses, navigating M&A, and transforming organisations for future success. In this discussion, we tackle a common misconception: Does hiring HR mean losing control, or does it actually help founders build a stronger, more resilient business?

We’re delighted to welcome Barbara Greutter as our newest Board Member at GENerX Life. Barbara brings deep expertise in HR leadership, M&A integration, and organisational transformation. A seasoned CHRO and strategic HR leader, Barbara has over 20 years of experience advising executive teams across Pharma, Biotech, Tech, and Consulting. She has played a pivotal role in scaling early-stage companies, driving market expansions, and leading HR transformations that fuel business success. Her expertise spans large-scale M&A integrations, post-merger transformations, and major restructuring initiatives across multiple countries. She has also led complex divestitures, emerging market expansions, and executive leadership development—helping HR leaders build high-performing, future-ready teams. At GENerX Life, we believe HR is at the core of business success. With Barbara’s strategic insight and hands-on experience, we are enhancing our ability to help HR leaders and executives navigate growth, transformation, and talent strategy—ensuring their organisations are built for the future. #Biotech #Pharma #LifeSciences #HRLeadership #ExecutiveLeadership #MergersAndAcquisitions #TalentStrategy #OrganisationalTransformation #ScalingStartups #GENerXLife

Last year, we had a big focus on AI and its applications in life sciences, and one and one particularly exciting subset of that is “digital twins.” Read our latest article about this fascinating technology, along with the leadership and talent challenges attached with its rapid adoption. #LifeSciences #DigitalTwins #AI #DataAnalytics #ClinicalResearch #PrecisionMedicine #HealthcareInnovation

As we continue to grow our business in the US, we are thrilled to announce that Rami Levin is joining our board. Rami’s extensive leadership experience in Life Sciences will be instrumental in providing strategic advice to our biotech community. Rami Levin is a seasoned biotech executive with nearly 30 years of leadership experience across the pharmaceutical and biotechnology sectors. He has led private and public companies, managed large P&Ls, driven scale-ups, and raised transformative capital. Rami has held prominent roles, including CEO of ImStem Biotechnology and Saniona, as well as President of Sobi Inc., where he built the North American team from the ground up, growing it to over 300 employees and generating $500M+ in annual revenue. He is also the Founder and CEO of The Outcomes Group, specializing in strategy and executive development for biotech leaders. We are excited to have Rami’s expertise guiding us as we continue to support emerging biotech's in their growth journeys. #LifeSciences #BiotechLeadership #StrategicGrowth #LeadershipExcellence #EmergingBiotechs #ScalingUp #BoardLeadership

In our 2024 Recap and Look Ahead to 2025, we take a dive into some of the most interesting topics that shaped the life sciences industry last year, including breakthrough therapies and "firsts," AI in the regulatory spotlight, talent and leadership insights and M&A activity. We also cover what trends we see as important coming into 2025 and why it's a year we can look forward to! #LifeSciences #Biotech #LeadershipDevelopment #AI

Founders, it’s time to face a hard truth: nearly 40% of new executives fail within their first 18 months, and in the high-stakes world of life sciences, those missteps can spell disaster. This article lays out the critical hiring traps many founders fall into - and how to avoid them. If you’re serious about building an executive team that won’t just survive but thrive, read on. Your company’s future may depend on it. #LifeSciences #ExecutiveHiring #StartupLeadership #FounderTips #TalentStrategy #Biotech

In our latest article, we explore what makes a great leader and why leadership is critical for innovation and success. Learn how tailored leadership programs can help organisations unlock potential, inspire teams, and shape future leaders in Life Sciences. #LeadershipDevelopment #LifeSciences #Coaching #Leadership #Innovation

GENerX Life is greatly proud and thankful for the opportunity and trust from Relation to run a #LeadershipDevelopment workshop with the team during their Inaugural Offsite earlier this month. Our expert leadership coach Kris Perquy spoke about #HighPerformance and #Teamwork in sports bringing a #WinningAttitude to biotech in a very #Interdisciplinary context.  With Kris, our other leadership coaches Crina Ancuta MD and Claes Zackrisson were delighted to facilitate an afternoon workshop with the whole team - and had a great time! Relation has a fantastic, diverse, and interdisciplinary team, positioning the company for an exciting future. We are sure they will continue driving innovation and making a difference because #ThePatientIsWaiting. Thank you to the leadership team, founders and investors for the great contributions and inspiration Rosie Rodriguez PhD Charles Campbell Roberts Jake P. Taylor-King Casey Benjamin Swerner David Roblin Edith Hessel Lindsay Edwards Christine Aylward Jason Pontin.

We’re thrilled to be here at the AI for Health conference in Paris today! It’s amazing to be surrounded by so many brilliant minds exploring how AI is changing the game in life sciences. We’re enjoying hearing from companies right at the forefront of AI innovation, from accelerating drug discovery to streamlining clinical trials, and more. A special highlight for us was seeing our advisory board member and AI expert, Iannis Drakos, and CEO, Jack Corbett, take to the stage to discuss “When AI Investments Pay Off,” delving into the different types of AI, actionable advice for executives with respect to AI integration, and common pitfalls companies face when adopting AI. We’ve already met some incredible people, and we’re looking forward to more meaningful conversations, so if you’re here, come and say hi. Let’s chat about where AI is headed and how great leadership can help make it happen! #AIforHealth #LifeSciencesLeadership #AI #Innovation #Biotech #GenerativeAI #HealthcareInnovation #GENerXLife